Hernández MJF, Solano SSR, Zúñiga LDS, Salomón KJ, Maldonado MEP

Language: Spanish
References: 16
Page: 276-279
PDF size: 37.05 Kb.

ABSTRACT

Objective: To establish if the pregnancy is associated with the development of overactive bladder. Material and methods: Study with cross-sectional design to compare the proportion of cases of overactive bladder in pregnancy women with the proportion of cases of overactive bladder in non pregnant women. The diagnosis of overactive bladder was realized according to a diagnosis questionnaire «VH8». Results: The prevalence of overactive bladder in pregnancy was 88%; prevalence ratio 4.97 IC (2.6-9.3); odds ratio 35 IC (11.6-104.9). The differences between the groups were statistically significant. Conclusion: In this study, we found that the overactive bladder displays a high prevalence in the pregnancy. Statistically significant association between the pregnancy and the development of this pathology exists.

REFERENCES

1. Bernard TH, Dirk de R, Robert M et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010; 21: 5-26.

2. Henriette J, Hein W, Geerte V, Peter M, Huub V et al. What is the effect of overactive bladder symptoms on woman’s quality of life during and after first pregnancy? BJU International 2006; 97: 296-300.

3. Bent A, Ostergard D, Cundiff G, Swift S. Uroginecología y disfunción del piso pélvico. 5a ed: México; McGraw-Hill, 2004: 44-49, 227-246, 297-311.

4. Griffiths D, Derbyshire S, Stenger A, Resnick N. Brain control of normal and overactive bladder. J Urol 2005; 174: 1862-1867.

5. Masaki Y, Koichi M, Takashi N, Makoto Y, Yukio H et al. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder. J Pharmacol Sci 2010; 112: 128-134.

6. O’Reilly BA, Kosaka AH, Chang TK, Ford AO, Popert R, McMahon SB et al. A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction. BJU Int 2001; 87: 617-622.

7. Ouslander JG. Geriatric considerations in the diagnosis and management of overactive bladder. Urology 2002; 60 (Suppl 1): 50-55.

8. Cutner A, Cardozo LD, Benness CJ. Assessment of urinary symptoms in the second half of pregnancy. Urodynamic Unit 1992; 3: 30-32.

9. Botelho S, Riccetto C, Ribeiro G, Gome J, Brisola M, Herrmann V, Palma P, Bigozzi MA y cols. Síntomas de vejiga hiperactiva en mujeres en fase gestacional y puerperal: ¿existe correlación entre los síntomas y la percepción de la calidad de vida? Actas Urol Esp 2010; 34: 794-797.

10. Coyne KS, Margolis MK, Zyczynski T, Elinoff V, Roberts R et al. Validation of an OAB screener in a primary care patient population in the US. Poster presented at the Annual Meeting of the International Continence Society, Aug. 23-27, 2004.

11. Sánchez M del P, Solano-Sánchez SR et al. Practice guidelines 2008. Mexican College of Obstetrics and Gynecology Specialists. Diagnosis and treatment of idiopathic overactive bladder. Ginecol Obstet Mex 2009; 77 (11): S331-70.

12. Van Brummen HJ, Bruinse HW, van der Bom JG, Heintz AP, van der Vaart CH. How do the prevalences of urogenital symptoms change during pregnancy? Neurourol Urodyn 2006; 25: 135-139.

13. Hong PL, Leong M, Seltzer V. Uroflowmetric observations in pregnancy. Neurourol Urodyn 1988; 7: 61-70.

14. Speroff L, Fritz M. Endocrinología ginecológica clínica y esterilidad. Capítulo 8. 7ª edición. Barcelona: Lippincott Williams & Wilkins; 2007: 286.

15. Solano-Sánchez SR. Prolactin plasma levels in women with and without idiophatic overactive bladder. Int Urogynecol J 2007; 18 (Suppl 1): S74.

16. Solano-Sánchez SR, Velázquez-Sánchez MP, Rodríguez-Colorado S, Kunhardt RJ. Comparative study of overactive bladder prevalence in patients younger than 50 years with and without hyperprolactinemia. Ginecol Obstet Mex 2006; 74 (7): 345-348.